Skip to main content
Welcome to
super saver spring
offer ends april 20
save over $140
save over 85%
$0.99
per week for 24 weeks
Welcome to
super saver spring
$0.99
per week
for 24 weeks
// //

The Northwest Territories says two recently announced infections have been identified as the COVID-19 variant first identified in the United Kingdom.

The cases include an out-of-territory worker at the Diavik Diamond Mine, 300 kilometres northeast of Yellowknife, and a N.W.T. resident in Yellowknife.

Last week, the territory identified its first variant case, another out-of-territory worker at the same mine, as the variant first identified in the U.K. Because the two workers are from outside the N.W.T., they are not counted in the territory’s COVID-19 database.

Story continues below advertisement

The territory’s chief public health officer, Dr. Kami Kandola, said the infected people and contacts are doing well, and there is no risk to the public at this time.

She said the Yellowknife case is related to international travel, but “was not communicable during air travel” and the person was tested upon returning to Canada.

Kandola also said her office is working with the Diavik mine to safely return local and out-of-territory workers home, and all workers on site will be tested.

Workers at the mine have also been offered the COVID-19 vaccine, and over 200 of them have been vaccinated.

Kandola said her office anticipated it would see variants enter the N.W.T. at some point during the pandemic and it’s prepared to handle them.

“These new variants are highly infectious and extremely dangerous,” Kandola said. “Widespread infection would be devastating to our health-care system and communities here in the Northwest Territories.”

Kandola also noted there “is excellent data” that shows the Moderna vaccine, the only vaccine available in the N.W.T., is effective against the U.K. variant.

Story continues below advertisement

To date, 24,103 people in the N.W.T. have received one dose of vaccine and 16, 259 have received the full two doses.

The N.W.T. sends a sample of the virus detected in all those diagnosed with COVID-19 to southern lab partners to test for variants of concern.

Editor’s note: This is a corrected story. A previous version said the variant cases were the first in the territory.
Health columnist André Picard answers reader questions about COVID-19 variants, how effective the various vaccines are and the impact of on-again, off-again lockdowns. The Globe and Mail

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters and editors.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies